Astrazeneca Plc (AZN-N) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr06/2026	Next Qtr09/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$2.52	$2.75	$10.28	$11.44
Number of Estimates	3	1	6	6
High Estimate	$2.56	$2.75	$10.52	$11.66
Low Estimate	$2.49	$2.75	$10.13	$11.10
Prior Year	$2.18	$2.38	$9.16	$10.28
Growth Rate Est. (year over year)	+15.60%	+15.55%	+12.23%	+11.28%

Earnings History - Surprises*

	Qtr Ending03/2026	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025
Reported	$2.58	$1.06	$2.38	$2.18
Estimate	$2.57	$2.18	$2.28	$2.18
Difference	+0.01	-1.12	+0.10	unch
Surprise	+0.39%	-51.38%	+4.39%	unch

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.41

3 Mths Ago22

4.50

2 Mths Ago22

4.50

1 Mth Ago22

4.50

Current22

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	22	22	22	22
	16 1	17 1	17 1	17 1
Holds	4	3	3	3
	1	1	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Two top TSX gainers this year that insiders love (and one big loser)

number cruncher

Seven airline stocks that could take flight as oil prices fall

Bullish on Gibson Energy Inc.

Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index

Friday’s analyst upgrades and downgrades

Will a new pipeline reinvigorate Canadian energy stocks?

number cruncher

Nine profitable global semiconductor companies

Bullish on Ford Motor Co.